Back to results
CompletedPhase 3

A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer

NCT00190489

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Cancer Center Hospital

Chuo-ku, Tsukiji, 5-1-1, Tokyo, Japan

View on ClinicalTrials.gov
A Trial of Doxorubicin/Cyclophosphamide (AC), Docetaxel (D), and Alternating AC and D for Metastatic Breast Cancer — TrialFind